CYP19A1 and breast carcinoma: Dysfunctional VAT secretes pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), thereby stimulating aromatase activity, which eventually drives higher estrogen production to support luminal type breast cancer growth5,6.